As the U.S. continues its struggle against the COVID-19 pandemic, staying safe is one of Americans’ top concerns. Safety is also essential for getting the economy back on track, as the lower COVID-19 transmission and deaths are in a state, the more that state is able to eliminate restrictions on businesses. We’ll only be able to fully get back to life as normal once most of the population is vaccinated against coronavirus, and it will still be months before we can achieve that. The U.S. is off to a slow start so far, as only 5% of the population has been fully vaccinated against COVID-19 (received both doses) as of February 17.
RICHMOND, Va. — When tiny glass vials of coronavirus vaccine began rolling off production lines late last year, federal health officials set aside a big stash for nursing homes being ravaged by the virus. Health providers around the country figured as well that it was prudent to squirrel away vials to ensure that everyone who got a first dose of vaccine got a second one.
Two months later, it is clear both strategies went overboard.
All across Europe, coronavirus vaccines are in scarce supply. But in France, they are also surprisingly unwanted: Recent polls suggest just 57% of the country intends to get vaccinated, whereas in the United Kingdom, 89% wants to get a shot for COVID-19.
